Evidence map›Paper›PMID 40884221›Full record

ArticleJournal of managed care & specialty pharmacy2025

AMCP Market Insights: Payer best practices for timely diagnosis and optimal management of idiopathic hypersomnia.

Bridget Flavin, Denise Wolff, Zachary Contreras, Ryan Haumschild, Diana Kimmel, Michael Kobernick, Farzana Rahman

Abstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bridget FlavinConnected Content, Ltd., Boulder, CO.
Denise WolffDenise & Co., LLC, Duluth, MN.
Zachary ContrerasSharp Health Plan, San Diego, CA.
Ryan HaumschildEmory Healthcare and Winship Cancer Institute, Atlanta, GA.
Diana KimmelHypersomnia Foundation, Atlanta, GA.
Michael KobernickBlue Cross Blue Shield of Michigan, Huntington Woods.
Farzana RahmanAmeriHealth Caritas, Vienna, VA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic hypersomnia (IH) is a chronic, neurologic disorder with a primary symptom of excessive daytime sleepiness. There are challenges to timely, accurate diagnosis of IH and, therefore, to optimal management. To better understand these challenges and identify opportunities, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2024. Key insights from the discussion related to addressing diagnostic challenges in IH, making coverage decisions for medications used in IH, and implementing coverage criteria for medications used in IH. Suggested payer best practices in IH also emerged from the discussion.

Indexed as

Idiopathic HypersomniaManaged Care ProgramsHumansUnited States

Identifiers

PMID40884221
PMCPMC12397975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.